SCHEMBL17128200

SCHEMBL17128200

COc1c(-c2ccc(N)nc2)cnc2c(-c3ccc(C#N)cc3)cccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.40
ALOX5AP P20292 2/20 0.39
FEN1 P39748 2/20 0.39
PARP1 P09874 1/20 0.38
USP7 Q93009 2/20 0.38
MAP3K11 Q16584 1/20 0.38
LRRK2 Q5S007 1/20 0.38
PDE10A Q9Y233 1/20 0.37
MAP4K4 O95819 2/20 0.36
MINK1 Q8N4C8 1/20 0.36
TNIK Q9UKE5 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
MAPKAPK2 P49137 1/20 0.35
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
KDM4A O75164 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
HPGDS O60760 1/20 0.35
KIT P10721 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17128203 0.87 IRAK4 (0.38) HRH4IRAK4PARP1PDE10ASLC22A12
SCHEMBL21336706 0.86 ALDH1A1 (0.39) HRH4IRAK4SLC22A12HPGDSFYN
SCHEMBL17127785 0.85 SQOR (0.41) HRH4IRAK4SLC22A12MAPKAPK2KDM4A
SCHEMBL17128379 0.85 HRH4 (0.38) HRH4IRAK4PARP1SLC22A12KDM4A
SCHEMBL17128140 0.85 HRH4 (0.44) HRH4IRAK4PARP1MAP4K4MINK1
SCHEMBL21336710 0.81 HRH4 (0.40) HRH4IRAK4PARP1SLC22A12MAPKAPK2
SCHEMBL17127906 0.80 HRH4 (0.39) HRH4IRAK4PARP1PDE10ASLC22A12
SCHEMBL17127609 0.80 HRH4 (0.39) HRH4IRAK4PARP1PDE10ASLC22A12
SCHEMBL17128318 0.79 BRS3 (0.43) HRH4IRAK4PARP1MAP4K4SLC22A12
SCHEMBL17128206 0.78 HRH4 (0.38) HRH4SLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015144001-A1 QUINOLINE DERIVATIVES AS SMO INHIBITORS 南京明德新药研发股份有限公司 2015-10-01 WO disclosed